Nationwide Campaign to Eliminate Lymphatic Filariasis | 14 Feb 2026

Why in News?

The Union Minister for Health and Family Welfare, launched the Annual Nationwide Mass Drug Administration (MDA) Campaign for the elimination of Lymphatic Filariasis (LF) across 12 endemic States of India. 

Key Points: 

• Mass Drug Administration (MDA) Campaign: To interrupt transmission of LF and achieve elimination as a public health problem. 
• Strategy: Annual administration of anti-filarial medicines to the entire eligible population, excluding pregnant women, infants below a certain age, and seriously ill individuals. 
• Drug Used: Drugs commonly used include Diethylcarbamazine (DEC), Albendazole, and in selected districts, Ivermectin (Triple Drug Therapy – IDA). 
• Target States: The campaign is being implemented across 12 endemic states: Andhra Pradesh, Assam, Bihar, Chhattisgarh, Gujarat, Jharkhand, Karnataka, Maharashtra, Madhya Pradesh, Odisha, Uttar Pradesh, and West Bengal. 
• Lymphatic Filariasis (LF):Lymphatic Filariasis is a neglected tropical disease (NTD) caused by parasitic worms (Wuchereria bancrofti, Brugia malayi). 
  • It is transmitted through the bite of infected mosquitoes. 
  • Chronic infection leads to conditions such as elephantiasis, hydrocele, and long-term disability. 
  • India accounts for a significant global burden of LF. 
• Ahead of Schedule: India's 2027 target reflects the nation's proactive stance in meeting Sustainable Development Goal (SDG 3) targets early.